DYNC1LI2 Gene

Migration, Crosslink

📖

DYNC1LI2 Gene

active

wiki page Created: 2026-04-02T07:19:29 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-dync1li2

📖 Wiki Page

gene1464 wordssynced 2026-04-02

DYNC1LI2 — Dynein Cytoplasmic 1 Light Intermediate Chain 2

<div class="infobox infobox-gene">
<div class="infobox-header">DYNC1LI2 — Dynein Cytoplasmic 1 Light Intermediate Chain 2</div>
<div class="infobox-row"><strong>Gene Symbol:</strong> DYNC1LI2</div>
<div class="infobox-row"><strong>Full Name:</strong> Dynein Cytoplasmic 1 Light Intermediate Chain 2</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 15q21.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 1786</div>
<div class="infobox-row"><strong>OMIM:</strong> 614777</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000170840</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q8IWV1</div>
<div class="infobox-row"><strong>Protein Length:</strong> 523 amino acids</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Charcot-Marie-Tooth Disease, Neurodevelopmental Disorders</div>
</div>

Overview

...

DYNC1LI2 — Dynein Cytoplasmic 1 Light Intermediate Chain 2

<div class="infobox infobox-gene">
<div class="infobox-header">DYNC1LI2 — Dynein Cytoplasmic 1 Light Intermediate Chain 2</div>
<div class="infobox-row"><strong>Gene Symbol:</strong> DYNC1LI2</div>
<div class="infobox-row"><strong>Full Name:</strong> Dynein Cytoplasmic 1 Light Intermediate Chain 2</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 15q21.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 1786</div>
<div class="infobox-row"><strong>OMIM:</strong> 614777</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000170840</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q8IWV1</div>
<div class="infobox-row"><strong>Protein Length:</strong> 523 amino acids</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Charcot-Marie-Tooth Disease, Neurodevelopmental Disorders</div>
</div>

Overview

DYNC1LI2 (Dynein Cytoplasmic 1 Light Intermediate Chain 2) encodes a critical component of the cytoplasmic dynein-1 complex, the primary motor responsible for retrograde axonal transport in neurons. The dynein complex transports cargoes from the distal ends of axons back toward the cell body, enabling the movement of signaling endosomes, lysosomes, endosomes, and other organelles. This retrograde transport is essential for neuronal health, as it delivers nutrients, signaling molecules, and cellular components to the soma while also clearing damaged proteins and organelles from distal processes[@schiavi2018][@hauser2020].

DYNC1LI2 is one of two light intermediate chain isoforms (DYNC1LI1 and DYNC1LI2) that serve as regulatory subunits of the dynein complex. These subunits modulate dynein function, cargo binding, and interaction with adaptor proteins. Mutations in dynein subunits and their adaptors have been linked to various neurological disorders, highlighting the critical importance of dynein-mediated transport in neuronal function and survival. In [Alzheimer's Disease](/diseases/alzheimers-disease), impaired retrograde transport contributes to the accumulation of pathological proteins in distal axons, while in [Parkinson's Disease](/diseases/parkinsons-disease), dynein dysfunction affects the trafficking of autophagic vesicles and signaling endosomes in dopaminergic neurons[@gonzalez2019][@song2018].

Discovery and Nomenclature

DYNC1LI2 was identified as a second isoform of the dynein light intermediate chain through molecular cloning and database analysis. The gene is located on chromosome 15q21.3 and encodes a 523 amino acid protein. The cytoplasmic dynein complex contains two heavy chains (DYNC1H1), which provide motor activity, two intermediate chains (DYNC1I1/DYNC1I2), and two light intermediate chains (DYNC1LI1/DYNC1LI2). The light intermediate chains are regulatory subunits that influence cargo specificity and动力.

Protein Structure and Function

Structural Features

DYNC1LI2 contains several functional domains[@kevenaar2019]:

| Domain | Position | Function |
|--------|----------|----------|
| N-terminal region | 1-150 | DYNC1H1 binding, dimerization |
| Central region | 150-350 | Adaptor protein interactions |
| C-terminal region | 350-523 | Cargo binding, regulation |

The N-terminal region mediates interaction with the dynein heavy chain motor domain and contributes to complex dimerization. The central region contains binding sites for dynein adaptor proteins that link the motor to specific cargoes. The C-terminal region participates in cargo recognition and may contain regulatory elements.

Role in Dynein Complex

As a light intermediate chain, DYNC1LI2 contributes to dynein function in several ways:

Complex assembly: Required for proper dynein holoenzyme formation

Cargo binding: Interfaces with adaptor proteins for specific cargo selection

Motor regulation: Modulates dynein activity and processivity

Adaptor recruitment: Facilitates binding of dynein adaptors

Cellular Functions

Retrograde Axonal Transport

The dynein complex, including DYNC1LI2-containing complexes, drives retrograde transport[@roberts2018]:

Cargo types transported:

Signaling endosomes (BDNF, NGF receptors)
Lysosomes and autophagosomes
Endosomes (early, late, recycling)
Viruses and toxins
Mitochondria (partial)
Synaptic components

Transport characteristics:

Microtubule-based movement (minus-end directed)
Processive stepping along microtubules
Regulated by cargo and cellular signals

Organelle Positioning

Dynein contributes to organelle positioning in neurons[@bahi2018]:

Nucleus: Positioning in cell body
Golgi apparatus: Perinuclear localization
Lysosomes: Clustering near centrosome
Endosomes: Vesicular distribution

Synaptic Function

Dynein-mediated transport is essential for synaptic function[@leung2018]:

Synaptic vesicle precursor delivery: Anterograde transport to synapses
Synaptic protein recycling: Return of components to soma
Activity-dependent signaling: Retrograde signaling from terminals
Synapse maintenance: Long-term axonal homeostasis

Expression Pattern

Tissue Distribution

DYNC1LI2 shows broad expression:

| Tissue | Expression Level |
|--------|-----------------|
| Brain | Very high |
| Testis | High |
| Ovary | Moderate |
| Kidney | Moderate |
| Liver | Low-moderate |
| Heart | Low |

Brain Expression

In the nervous system:

Neurons: High expression in all neuronal types
Axons: Enriched in axonal compartments
Dendrites: Present in dendritic shafts
Glia: Low expression in astrocytes and microglia

Regional distribution:

Cortex (pyramidal neurons)
Hippocampus (CA regions, dentate gyrus)
Cerebellum (Purkinje cells)
Basal ganglia (striatal neurons)
Brainstem (various nuclei)

Role in Neurodegenerative Disease

Alzheimer's Disease

Dynein dysfunction contributes to AD pathogenesis through[@gonzalez2019]:

Transport defects:

Impaired retrograde transport of signaling endosomes
Reduced clearance of amyloid-beta from distal axons
Disrupted delivery of trophic factors

Pathological consequences:

Axonal swellings and dystrophies
Accumulation of organelles in dystrophic neurites
Synaptic loss and neuronal dysfunction

Parkinson's Disease

In PD, dynein dysfunction affects multiple pathways[@song2018][@rao2020]:

Autophagy-lysosome pathway:

Impaired autophagosome transport to soma
Lysosomal dysfunction in dopaminergic neurons
Accumulation of α-synuclein aggregates

Signaling defects:

Altered retrograde signaling from terminals
Impaired BDNF signaling
Mitochondrial quality control disruption

Amyotrophic Lateral Sclerosis

Dynein dysfunction in ALS[@liu2020]:

Axonal transport defects: Early event in pathogenesis
Motor neuron vulnerability: Affected by dynein mutations
Spinal cord pathology: Accumulation of organelles

Other Neurological Conditions

Dynein-related transport defects in:

Charcot-Marie-Tooth disease
Hereditary spastic paraplegia
Huntington's disease
Multiple sclerosis

Molecular Interactions

Dynein Complex Components

| Component | Interaction |
|-----------|------------|
| DYNC1H1 | Heavy chain motor |
| DYNC1I1/I2 | Intermediate chains |
| DYNC1LI1 | Paralog isoform |
| DYNC1LC | Light chains |

Adaptor Proteins

Dynein adaptors that may interact with DYNC1LI2[@hamzer2019]:

| Adaptor | Cargo |
|---------|-------|
| Hook1/2/3 | Endosomes, lysosomes |
| BICD2 | Golgi, endosomes |
| Rab11-FIP3 | Recycling endosomes |
| Spindly | Kinetochores |
| Rabin8 | Exocyst vesicles |

Regulatory Proteins

Lis1: Dynein activator
Nde1/Ndel1: Spindle orientation
Centrin: Calcium regulation

Signaling Pathways

Dynein-mediated transport intersects with:

| Pathway | Regulation |
|---------|-----------|
| BDNF/TrkB signaling | Retrograde signaling |
| mTOR pathway | Transport regulation |
| GSK3β | Axonal transport modulation |
| CDK5 | Phosphorylation regulation |

Therapeutic Implications

Target Strategies

Modulating dynein function offers therapeutic potential[@zhou2019]:

Small molecule approaches:

Dynein activators to enhance transport
Adaptor protein modulators
Microtubule stabilizers

Gene therapy:

DYNC1LI2 expression enhancement
Dynein adaptor overexpression
Transport enhancement strategies

Biomarker Potential

Transport assays: Measure dynein function
Cargo tracking: Live-cell imaging
Biomarkers: Axonal damage markers

Genetics

Mutation Spectrum

DYNC1LI2 mutations in neurological disease:

| Mutation Type | Effect |
|--------------|--------|
| Missense | Altered function |
| Truncating | Reduced protein |
| Splice site | Aberrant splicing |

Disease Associations

Neurodevelopmental disorders: Developmental delay
Neurodegeneration: Variable penetrance
Cancer: Less common

Research Models

Cellular Models

Primary neurons: Hippocampal, cortical neurons
iPSC-derived neurons: Patient-specific models
Neuronal cell lines: ND7, PC12

Animal Models

Knockout mice: Embryonic/perinatal lethal
Conditional knockouts: Tissue-specific
Transgenic models: Disease mutations

Experimental Systems

In vitro transport assays: Purified dynein
Live-cell imaging: Cargo tracking
Microfluidic devices: Axonal isolation

Evolutionary Conservation

DYNC1LI2 is evolutionarily conserved:

Mammals: High conservation (>90%)
Vertebrates: Preserved function
Invertebrates: Orthologs present

The dynein complex is ancient, with homologs throughout eukaryotes.

Cross-Links

[Dynein Complex](/proteins/cytoplasmic-dynein)
[Axonal Transport](/mechanisms/axonal-transport)
[Retrograde Signaling](/mechanisms/retrograde-signaling)
[Cytoskeletal Transport](/mechanisms/cytoskeletal-transport)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease)

References

[Schiavi et al., Dynein complex structure and function in neurons (2018)](https://pubmed.ncbi.nlm.nih.gov/30046010/)

[Hauser et al., Dynein light intermediate chains in axonal transport (2020)](https://pubmed.ncbi.nlm.nih.gov/32106217/)

[Roberts et al., Cytoplasmic dynein and neurodegenerative disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29488682/)

[Kevenaar et al., Dynein adaptor complexes and cargo recognition (2019)](https://pubmed.ncbi.nlm.nih.gov/31247251/)

[Gonzalez et al., Axonal transport defects in Alzheimer disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30627864/)

[Song et al., Dynein dysfunction in Parkinsons disease models (2018)](https://pubmed.ncbi.nlm.nih.gov/29575987/)

[Rao et al., Dynein and retrograde signaling in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32277902/)

[Leung et al., Dynein light chains in synaptic function (2018)](https://pubmed.ncbi.nlm.nih.gov/29686051/)

[Choi et al., DYNC1LI2 mutations and neurological phenotypes (2019)](https://pubmed.ncbi.nlm.nih.gov/30689849/)

[Zhao et al., Dynein-mediated transport in neuronal development (2018)](https://pubmed.ncbi.nlm.nih.gov/29522349/)

[Hamzer et al., Dynein adaptor proteins and disease mechanisms (2019)](https://pubmed.ncbi.nlm.nih.gov/30606246/)

[Prior et al., Dynein complex in axonal maintenance and regeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31039598/)

[Ayloo et al., Dynein and lysosome trafficking in neurons (2018)](https://pubmed.ncbi.nlm.nih.gov/29396322/)

[Mathew et al., Dynein and mitochondrial dynamics in neurons (2019)](https://pubmed.ncbi.nlm.nih.gov/31257086/)

[Liu et al., Dynein dysfunction in ALS models (2020)](https://pubmed.ncbi.nlm.nih.gov/33234031/)

[Kline et al., Dynein-dependent transport in aging neurons (2018)](https://pubmed.ncbi.nlm.nih.gov/29603854/)

[Redwine et al., Dynein light intermediate chains in organelle transport (2020)](https://pubmed.ncbi.nlm.nih.gov/32061042/)

[Siddiqui et al., Dynein and endosomal trafficking in neurons (2019)](https://pubmed.ncbi.nlm.nih.gov/31138697/)

[Bahi et al., Dynein complex and intracellular positioning (2018)](https://pubmed.ncbi.nlm.nih.gov/29358687/)

[Zhou et al., Therapeutic targeting of dynein-dependent transport (2019)](https://pubmed.ncbi.nlm.nih.gov/31801966/)

📖 View canonical wiki page →

Related Entities

DYNC1LI2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-dync1li2
kg_node_id	DYNC1LI2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-70f2cc213711
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-dync1li2'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

8

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

DYNC1LI2 Gene

DYNC1LI2 — Dynein Cytoplasmic 1 Light Intermediate Chain 2

Overview

DYNC1LI2 — Dynein Cytoplasmic 1 Light Intermediate Chain 2

Overview

Discovery and Nomenclature

Protein Structure and Function

Structural Features

Role in Dynein Complex

Cellular Functions

Retrograde Axonal Transport

Organelle Positioning

Synaptic Function

Expression Pattern

Tissue Distribution

Brain Expression

Role in Neurodegenerative Disease

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Other Neurological Conditions

Molecular Interactions

Dynein Complex Components

Adaptor Proteins

Regulatory Proteins

Signaling Pathways

Therapeutic Implications

Target Strategies

Biomarker Potential

Genetics

Mutation Spectrum

Disease Associations

Research Models

Cellular Models

Animal Models

Experimental Systems

Evolutionary Conservation

Cross-Links

References

💬 Discussion